Overall, while further research is needed to fully understand LCM’s anticancer mechanisms, its capacity to modulate sodium channels, histone deacetylase, CRMP-2, and various microRNAs suggests a promising role as a novel therapeutic agent in cancer treatment. The gene discussed is DPYSL2; the disease is cancer.